Why the study?
Does influenza vaccination prevent cardiovascular complications in patients with cardiovascular disease?
Does influenza vaccination prevent cardiovascular complications in patients with cardiovascular disease?
Answers are grounded in this paper and cite their sources.
An Indian expert consensus strongly advocates for routine influenza vaccination in patients with cardiovascular disease to prevent acute cardiac events.
Cardiovascular disease represents a significant and growing public health challenge in India, with a notably higher burden of premature deaths compared to global averages. Concurrently, influenza infections contribute substantially to this burden by triggering cardiovascular complications, particularly among high-risk individuals. Despite evidence supporting the cardioprotective benefits of influenza vaccination, its integration into standard cardiology practice remains inconsistent. This consensus aims to deliver a comprehensive and detailed summary of the impact of influenza infections on cardiovascular disease, particularly in the Indian context, and to advocate for the adoption of influenza immunization as a defense against cardiac distress. The findings emphasize the importance of influenza vaccination in reducing the incidence of acute coronary syndrome, myocardial infarction, and other severe cardiovascular complications. It also discusses expert opinions concerning the role of vaccination against influenza in cardiovascular disease patients, highlighting the necessity of broader implementation in high-risk populations.
No takes yet. Share an insight, caveat, or question.
NAIR et al. (2026) conducted a review in Cardiovascular disease. Influenza vaccination was evaluated. Influenza vaccination is recommended by Indian experts to reduce the incidence of acute coronary syndrome, myocardial infarction, and severe cardiovascular complications in high-risk populations.
Synapse has enriched 10 related papers. Consider them for comparative context: